The GMP Insider
By Tushar Arora
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Tushar Arora
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 74
Description
GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance.
Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality cultures.
Whether you work in Quality Assurance, Quality Control, Manufacturing, or Regulatory Affairs, GMP Insider helps you stay compliant, confident, and ahead in an ever-evolving pharmaceutical industry.
New episodes deliver:
• GMP best practices
• Audit readiness strategies
• Real compliance case studies
• Industry trends and updates
• Expert tips from quality professionals
From batch to patient — quality is everything.
| Episode | Date |
|---|---|
|
Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained
|
Oct 21, 2026 |
|
Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained
|
Oct 21, 2026 |
|
OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192)
|
Oct 19, 2026 |
|
ALCOA+ Explained: The 9 Data Integrity Principles FDA Actually Cites
|
Oct 14, 2026 |
|
Top 10 FDA 483 Observations in 2026 (and How to Avoid Each One)
|
Oct 12, 2026 |
|
Quality Debt: The Hidden Liability Inside Pharmaceutical Quality Systems
|
Oct 07, 2026 |
|
The Hidden Cost of Poor Quality: The Business Impact Beyond Recalls
|
Oct 05, 2026 |
|
Why CAPA Doesn't Fix Culture: Symptoms vs Systems
|
Sep 30, 2026 |
|
Compliance vs Effectiveness: Is Your Quality System Healthy?
|
Sep 28, 2026 |
|
When a Green Dashboard Lies: Signals Your Metrics Miss
|
Sep 23, 2026 |
|
When Quality Has to Say NO: Tough QA Decisions in Pharma
|
Sep 21, 2026 |
|
AI Governance in Pharma: Ethics by Design for Quality Leaders
|
Sep 13, 2026 |
|
Big Pharma vs Small Pharma: Where Quality Culture Thrives
|
Sep 13, 2026 |
|
The Human Side of Pharma Quality: Quality Is Love in Action
|
Sep 13, 2026 |
|
QA Leadership: Making Difficult Quality Decisions with Confidence
|
Sep 13, 2026 |
|
The Most Dangerous Day in Quality: When Questions Stop
|
Sep 13, 2026 |
|
Beyond CAPA Closure: The QA Judgment That Gets You Promoted
|
Aug 23, 2026 |
|
The One Lesson Nobody Teaches You in QA
|
Aug 16, 2026 |
|
Quality by Character: Confidence Through Leadership
|
Jul 27, 2026 |
|
Quality by Service: Patients, Not Auditors
|
Jul 27, 2026 |
|
Quality by Purpose: Why You Chose Pharma QA
|
Jul 27, 2026 |
|
Quality by Trust: Why Patients Trust Pharma QA
|
Jul 23, 2026 |
|
Quality by Humility: What Every Deviation Teaches QA
|
Jul 21, 2026 |
|
Quality by Ownership: Quality Is Everyone's Responsibility
|
Jul 21, 2026 |
|
Quality by Integrity: Doing Right When Nobody Is Watching
|
Jul 18, 2026 |
|
Quality by Curiosity: Better Questions in Pharma QA
|
Jul 18, 2026 |
|
Quality by Courage: Speaking Up Protects Patients
|
Jul 18, 2026 |
|
WE CARE: The Heart of Pharmaceutical Quality
|
Jul 16, 2026 |
|
Quality by Emotion: The Missing Piece in Pharma QA
|
Jul 16, 2026 |
|
Data Integrity in Pharma: It Starts Before Data Is Created
|
Jun 29, 2026 |
|
FDA Inspection Readiness: A Daily Habit, Not a Project
|
Jun 29, 2026 |
|
AI Governance in Pharma: The Next Big Challenge for QA
|
Jun 29, 2026 |
|
Weak CAPAs: The Hidden Cost of Closing Without Fixing
|
Jun 29, 2026 |
|
Quality by Design vs Inspection: What Works in Pharma QA
|
Jun 29, 2026 |
|
WE DO: The Quality Mindset That Protects Patients
|
Jun 04, 2026 |
|
Every NO Gets You Closer to YES: A QA Mindset for Pharma
|
Jun 04, 2026 |
|
AI in Pharma QA: Why Trust Matters More Than Technology
|
May 31, 2026 |
|
QA Career Growth: Stop Sabotaging Your Potential in Pharma
|
May 31, 2026 |
|
Focused Work in Pharma QA: Your Competitive Advantage
|
May 27, 2026 |
|
Fixed vs Growth Mindset in Pharma Quality
|
May 27, 2026 |
|
Why Quality Failures Never Happen Overnight in Pharma
|
May 03, 2026 |
|
Deep Work in Pharma QA: Focus That Improves Quality Systems
|
May 03, 2026 |
|
Quality Is Not a Department: The Bigger Picture in Pharma
|
Apr 19, 2026 |
|
QA Mistakes That Keep Weak Quality Systems Alive
|
Apr 19, 2026 |
|
Risk Management in Pharma: Lessons from Artemis II
|
Apr 19, 2026 |
|
The LISTEN Model: Better Thinking for Pharma QA
|
Apr 13, 2026 |
|
"Retraining" Is the Most Overused CAPA in Pharma — Here's Why
|
Apr 12, 2026 |
|
Why People Stay Silent in Weak Quality Cultures
|
Mar 29, 2026 |
|
"We've Always Done It This Way": Pharma's Most Dangerous Phrase
|
Mar 29, 2026 |
|
Activity vs Effectiveness: What FDA Really Wants to See
|
Mar 29, 2026 |
|
"Human Error" Is Not a Root Cause: QA Investigation Mistake
|
Mar 29, 2026 |
|
How FDA Inspects Biologics: Risk-Based GMP Explained
|
Mar 29, 2026 |
|
AI Meets FDA: Why Credibility Beats Capability in Pharma
|
Mar 29, 2026 |
|
FDA 483 Response Guide: What to Do After an Inspection
|
Mar 08, 2026 |
|
Process Optimization in Pharma: Lessons from Ford v Ferrari
|
Mar 02, 2026 |
|
Continuous Improvement in Pharma: Lessons from The Martian
|
Mar 01, 2026 |
|
AI Adoption in Pharma: A Quality Leader's Guide
|
Mar 01, 2026 |
|
The Architecture of Trust: AI Governance in Pharma
|
Mar 01, 2026 |
|
Deviations & Root Cause: Lessons from Apollo 13
|
Feb 23, 2026 |
|
Clinical QA Explained: Building Trust in Trial Data
|
Feb 22, 2026 |
|
Pharmacovigilance Quality: Guardian of Patient Safety
|
Feb 22, 2026 |
|
6 Skills Every New Pharma QA Professional Needs
|
Feb 22, 2026 |
|
Clinical QA vs Commercial QA vs PV QA: Can You Switch?
|
Feb 22, 2026 |
|
Clinical QA vs Commercial QA vs PV QA Roles Explained
|
Feb 22, 2026 |
|
Stop Asking "Is It Compliant?" Ask "Is It Under Control?"
|
Feb 13, 2026 |
|
Data Integrity in Pharma: System Design, Not Documentation
|
Feb 13, 2026 |
|
Trend Analysis in Pharma QA: Preventing FDA Findings
|
Feb 08, 2026 |
|
Compliance Drift: Why Leadership Owns Quality Failures
|
Feb 08, 2026 |
|
Training vs Compliance: What FDA Really Looks For
|
Feb 08, 2026 |
|
Deviation Investigation: Why Blaming People Fails GMP
|
Feb 08, 2026 |
|
FDA Inspection Readiness: Stop Treating It Like a Project
|
Feb 03, 2026 |
|
Quality as the Architecture of Risk Management
|
Feb 03, 2026 |
|
Data Integrity in GMP: From Trust to System Control
|
Jan 30, 2026 |
|
Root Cause Analysis Explained Simply (Mickey Mouse Method)
|
Jan 27, 2026 |